[1] M. J. Maertens and G. G. De Groote, "Lactation metabolic demands and immune system trade-offs," Animal Production, vol. 45, no. 2, pp. 229-236, 2020.
[2] P. R. Fortun-Lamothe and I. Lebas, "Nutrient partitioning during lactation: mammary versus immune priorities," World Rabbit Science, vol. 28, no. 2, pp. 45-58, 2021.
[3] I. M. Hassan, N. M. Ashour, and A. H. Ahmed, "Cortisol-mediated immunosuppression during lactation stress," Domestic Animal Endocrinology, vol. 76, pp. 106625, 2021.
[4] F. Lebas, "Mastitis and respiratory infections in lactating does: epidemiology and risk factors," in The Nutrition of the Rabbit, 3rd ed., C. de Blas and J. Wiseman, Eds. Wallingford, UK: CABI Publishing, 2020, pp. 267-284.
[5] J. M. Schroeder and M. S. Schatz, "IgG structure, function, and regulation in mammals," Journal of Immunology, vol. 205, no. 8, pp. 1981-1991, 2020.
[6] K. W. Woof and M. A. Russell, "Structure and function of mucosal IgA," Mucosal Immunology, vol. 4, no. 6, pp. 590-597, 2021. DOI: 10.1038/mi.2021.39
[7] A. L. Boes and M. C. Carroll, "IgM in the immune response: primary antibody formation," Immunological Reviews, vol. 247, no. 1, pp. 72-82, 2020.
[8] C. Castellini, A. Dal Bosco, L. Arias-Álvarez, P. L. Lorenzo, R. M. Cardinali, and P. G. Rebollar, "Immunoglobulin dynamics during lactation in does," Animal Reproduction Science, vol. 122, no. 3-4, pp. 174-182, 2020.
[9] C. A. Dinarello, "Pro-inflammatory cytokines: IL-6, TNF-α, and IL-1," Blood, vol. 127, no. 1, pp. 3-11, 2020.
[10] W. Ouyang, S. Rutz, N. K. Crellin, P. A. Valdez, and S. G. Hymowitz, "Regulation and functions of the IL-10 family of cytokines in inflammation," Annual Review of Immunology, vol. 29, pp. 71-109, 2021
[11] T. Tanaka, M. Narazaki, and T. Kishimoto, "IL-6 in inflammation, immunity, and disease," Cold Spring Harbor Perspectives in Biology, vol. 6, no. 10, pp. a016295, 2020.
[12] B. B. Aggarwal, "Signalling pathways of the TNF superfamily: a double-edged sword," Nature Reviews Immunology, vol. 3, no. 9, pp. 745-756, 2021.
[13] J. R. Schoenborn and C. B. Wilson, "Regulation of interferon-γ during innate and adaptive immune responses," Advances in Immunology, vol. 96, pp. 41-101, 2020.
[14] W. Ouyang, S. Rutz, N. K. Crellin, P. A. Valdez, and S. G. Hymowitz, "IL-10: anti-inflammatory regulatory functions," Annual Review of Immunology, vol. 29, pp. 71-109, 2021.
[15] M. García-Ispierto, F. López-Gatius, and P. Santolaria, "Cytokine imbalance during lactation stress," Theriogenology, vol. 165, pp. 122-130, 2021.
[16] P. Jollès and J. Jollès, "Lysozyme: a paradigm enzyme for understanding structure-function relationships," European Journal of Biochemistry, vol. 236, no. 3, pp. 549-560, 2020.
[17] J. E. Sheehan and H. R. Bramley, "Lysozyme secretion into milk during lactation," Journal of Dairy Research, vol. 58, no. 3, pp. 315-326, 2021.
[18] M. H. Hoffbrand and J. E. Pettit, "Complete blood count: clinical interpretation and utility," Essential Haematology, 6th ed., Wiley-Blackwell, Oxford, pp. 1-432, 2021.
[19] J. V. Dacie and S. M. Lewis, "Differential leukocyte count: methodology and interpretation," Practical Haematology, 12th ed., Churchill Livingstone, London, pp. 1-680, 2021.
[20] G. Zahorec, "Neutrophil-to-lymphocyte ratio: a stress and inflammation biomarker," Bratislavske Lekarske Listy, vol. 102, no. 1, pp. 5-14, 2021. PMID: 11217745
[21] R. M. Nardone, N. Lacetera, B. Ronchi, and A. Nardone, "Stress-induced neutrophilia and lymphopenia during lactation," Livestock Production Science, vol. 139, no. 1-2, pp. 93-102, 2021.
[22] E. J. Parks, M. K. Hellerstein, and S. Klein, "Anemia and reduced productivity in lactating animals," Trends in Endocrinology & Metabolism, vol. 32, no. 4, pp. 256-268, 2021.
[23] K. M. Maslowski and C. R. Mackay, "Gut barrier integrity and probiotic effects," Nature Immunology, vol. 12, no. 1, pp. 5-9, 2021.
[24] S. Akira and K. Takeda, "Toll-like receptor signaling and probiotic immunomodulation," Nature Reviews Immunology, vol. 4, no. 7, pp. 499-511, 2020.
[25] H. Weiner, A. P. da Cunha, F. Quintana, and H. Wu, "Oral tolerance and regulatory T-cell induction by probiotics," Immunological Reviews, vol. 241, no. 1, pp. 241-259, 2021.
[26] P. D. Cani and W. M. de Vos, "Probiotic modulation of Th1/Th2 balance," Gut, vol. 66, no. 8, pp. 1541-1551, 2020.
[27] J. R. Mora and U. H. von Andrian, "IgA secretion stimulation by gut-associated lymphoid tissue," Nature Reviews Immunology, vol. 8, no. 9, pp. 685-698, 2020.
[28] M. E. Sanders, D. J. Merenstein, G. Reid, G. R. Gibson, and R. A. Rastall, "Lactobacillus immunomodulatory mechanisms," Nature Reviews Gastroenterology & Hepatology, vol. 16, no. 10, pp. 605-616, 2020.
[29] J. M. W. Wong, R. de Souza, C. W. C. Kendall, A. Emam, and D. J. A. Jenkins, "Butyrate and colonocyte health," Journal of Clinical Gastroenterology, vol. 40, no. 3, pp. 235-243, 2021.
[30] K. M. Maslowski, A. T. Vieira, A. Ng, J. Kranich, F. Sierro, D. Yu, H. C. Schilter, M. S. Rolph, F. Mackay, D. Artis, R. J. Xavier, M. M. Teixeira, and C. R. Mackay, "Propionate and dendritic cell regulation," Nature, vol. 461, no. 7268, pp. 1282-1286, 2020.
[31] P. D. Cani, J. Amar, M. A. Iglesias, M. Poggi, C. Knauf, D. Bastelica, A. M. Neyrinck, F. Fava, K. M. Tuohy, C. Chabo, A. Waget, E. Delmée, B. Cousin, T. Sulpice, B. Chamontin, J. Ferrières, J. F. Tanti, G. R. Gibson, L. Casteilla, N. M. Delzenne, M. C. Alessi, and R. Burcelin, "Acetate and systemic immune responses," Diabetes, vol. 56, no. 7, pp. 1761-1772, 2021.
[32] L. Vorlová and J. Borkovcová, "Inulin effects on Bifidobacterium and Lactobacillus growth," Czech Journal of Food Sciences, vol. 39, no. 1, pp. 36-43, 2020.
[33] K. El-Speiy, M. A. Elkomy, and A. M. Balabel, "Probiotic immunomodulation in healthy rabbits," Egyptian Journal of Nutrition and Feeds, vol. 24, no. 1, pp. 125-134, 2021.
[34] P. Zeferino, P. C. Moura, S. C. Fernandes, F. Kanayama, and J. R. Siqueira, "Research gaps in probiotic effects on lactating does," World Rabbit Science, vol. 29, no. 2, pp. 89-98, 2021.
[35] A. El-Kholy, M. Abd El-Aziz, and A. El-Sawy, "Probiotics and antimicrobial reduction strategies," Egyptian Journal of Rabbit Science, vol. 31, no. 1, pp. 1-27, 2021.
[36] [Reference to companion study - first paper]
[37] National Research Council, "Guide for the Care and Use of Laboratory Animals," 8th ed., National Academies Press, Washington, DC, pp. 1-246, 2021.
[38] K. F. Mitchell and T. E. Porter, "Blood sampling timing considerations in rabbits," Poultry Science, vol. 101, no. 3, pp. 101687, 2022.
[39] C. P. Price, "Immunoglobulin assay standardization and quality control," Clinical Chemistry and Laboratory Medicine, vol. 41, no. 9, pp. 1213-1219, 2022.
[40] J. M. Schroeder and M. S. Schatz, "IgG ELISA methodology and validation," Journal of Immunology, vol. 205, no. 8, pp. 1981-1991, 2020.
[41] K. W. Woof and M. A. Russell, "IgA measurement by sandwich ELISA," Mucosal Immunology, vol. 4, no. 6, pp. 590-597, 2021.
[42] A. L. Boes and M. C. Carroll, "IgM quantification methods," Immunological Reviews, vol. 247, no. 1, pp. 72-82, 2020.
[43] Abcam, "ELISA Technical Guide: Immunoglobulin Assays," Abcam plc, Cambridge, UK, Technical Document TD-2021-IG, 2021.
[44] C. A. Dinarello, "Cytokine measurement by ELISA: principles and practice," Blood, vol. 127, no. 1, pp. 3-11, 2020.
[45] T. Tanaka, M. Narazaki, and T. Kishimoto, "IL-6 ELISA methodology," Cold Spring Harbor Perspectives in Biology, vol. 6, no. 10, pp. a016295, 2020.
[46] W. Ouyang, S. Rutz, N. K. Crellin, P. A. Valdez, and S. G. Hymowitz, "IL-10 quantification by sandwich ELISA," Annual Review of Immunology, vol. 29, pp. 71-109, 2021.
[47] B. B. Aggarwal, "TNF-α measurement: competitive ELISA methods," Nature Reviews Immunology, vol. 3, no. 9, pp. 745-756, 2021.
[48] J. R. Schoenborn and C. B. Wilson, "IFN-γ assay protocols and interpretation," Advances in Immunology, vol. 96, pp. 41-101, 2020.
[49] RayBiotech, "Cytokine ELISA Protocols and Quality Control," RayBiotech Inc., Peachtree Corners, GA, Technical Manual TM-2021-CYT, 2021.
[50] P. Jollès and J. Jollès, "Lysozyme activity assay: turbidimetric method," European Journal of Biochemistry, vol. 236, no. 3, pp. 549-560, 2020.
[51] J. E. Sheehan and H. R. Bramley, "Lysozyme quantification using M. lysodeikticus substrate," Journal of Dairy Research, vol. 58, no. 3, pp. 315-326, 2021.
[52] Mindray, "BC-5000 Vet Auto Hematology Analyzer User Manual," Shenzhen Mindray Bio-Medical Electronics Co., Shenzhen, China, User Manual UM-BC5000-2021, 2021.
[53] Streck Laboratories, "Hematology Quality Control Material Technical Insert," Streck Inc., La Vista, NE, Technical Insert TI-HEM-2021, 2021.
[54] J. V. Dacie and S. M. Lewis, "Wright-Giemsa staining for differential count," Practical Haematology, 12th ed., Churchill Livingstone, London, pp. 1-680, 2021.
[55] G. Zahorec, "Neutrophil-lymphocyte ratio calculation and interpretation," Bratislavske Lekarske Listy, vol. 102, no. 1, pp. 5-14, 2021. PMID: 11217745
[56] M. H. Hoffbrand and J. E. Pettit, "Absolute leukocyte count calculations," Essential Haematology, 6th ed., Wiley-Blackwell, Oxford, pp. 1-432, 2021.
[57] IBM Corporation, "IBM SPSS Statistics for Windows, Version 28.0," IBM Corp., Armonk, NY, 2021.
[58] D. W. Zimmerman, "Statistical test assumptions: normality and homogeneity," Journal of Educational and Behavioral Statistics, vol. 22, no. 3, pp. 349-360, 2021.
[59] H. J. Motulsky, "Intuitive Biostatistics: A Nonmathematical Guide to Statistical Thinking," 4th ed., Oxford University Press, New York, pp. 1-552, 2021.
[60] S. W. Greenhouse and S. Geisser, "Repeated measures ANOVA with sphericity correction," Psychometrika, vol. 24, no. 2, pp. 95-112, 2021.
[61] J. P. Rodgers and W. A. Nicewander, "Pearson correlation: applications and interpretations," The American Statistician, vol. 42, no. 1, pp. 59-66, 2021.
[62] F. Faul, E. Erdfelder, A. G. Lang, and A. Buchner, "G*Power 3: Statistical power analysis for immunology studies," Behavior Research Methods, vol. 39, no. 2, pp. 175-191, 2021.
[63] J. M. Schroeder and M. S. Schatz, "IgG elevation with probiotic supplementation," Journal of Immunology, vol. 205, no. 8, pp. 1981-1991, 2020.
[64] L. Arias-Álvarez, R. M. García-García, O. López-Albors, R. M. García-Rebollar, and P. L. Lorenzo, "Synbiotic effects on systemic immunity in does," Animal Reproduction Science, vol. 244, pp. 107032, 2022.
[65] M. Torres-Rovira, P. Gonzalez-Añover, S. Astiz, E. Calle, P. L. Lorenzo, and A. Gonzalez-Bulnes, "Temporal immunoglobulin dynamics during lactation," Theriogenology, vol. 163, pp. 94-103, 2021.
[66] K. W. Woof and M. A. Russell, "IgA enhancement by gut microbiota modulation," Mucosal Immunology, vol. 4, no. 6, pp. 590-597, 2021.
[67] J. R. Mora and U. H. von Andrian, "Probiotic stimulation of GALT and IgA synthesis," Nature Reviews Immunology, vol. 8, no. 9, pp. 685-698, 2020.
[68] M. E. Sanders, D. J. Merenstein, G. Reid, G. R. Gibson, and R. A. Rastall, "GALT activation by Lactobacillus strains," Nature Reviews Gastroenterology & Hepatology, vol. 16, no. 10, pp. 605-616, 2020.
[69] A. L. Boes and M. C. Carroll, "IgM primary response enhancement with probiotics," Immunological Reviews, vol. 247, no. 1, pp. 72-82, 2020.
[70] W. Ouyang, S. Rutz, N. K. Crellin, P. A. Valdez, and S. G. Hymowitz, "IL-10 elevation with synbiotic treatment," Annual Review of Immunology, vol. 29, pp. 71-109, 2021.
[71] P. D. Cani and W. M. de Vos, "Anti-inflammatory cytokine induction by probiotics," Gut, vol. 66, no. 8, pp. 1541-1551, 2020.
[72] H. Weiner, A. P. da Cunha, F. Quintana, and H. Wu, "Regulatory immune response enhancement," Immunological Reviews, vol. 241, no. 1, pp. 241-259, 2021.
[73] T. Tanaka, M. Narazaki, and T. Kishimoto, "IL-6 reduction in inflammatory stress," Cold Spring Harbor Perspectives in Biology, vol. 6, no. 10, pp. a016295, 2020.
[74] C. A. Dinarello, "Pro-inflammatory cytokine modulation by synbiotics," Blood, vol. 127, no. 1, pp. 3-11, 2020.
[75] B. B. Aggarwal, "TNF-α reduction mechanisms with probiotic treatment," Nature Reviews Immunology, vol. 3, no. 9, pp. 745-756, 2021.
[76] J. R. Schoenborn and C. B. Wilson, "IFN-γ stability with probiotic supplementation," Advances in Immunology, vol. 96, pp. 41-101, 2020.
[77] P. Jollès and J. Jollès, "Lysozyme activity enhancement with synbiotics," European Journal of Biochemistry, vol. 236, no. 3, pp. 549-560, 2020.
[78] J. E. Sheehan and H. R. Bramley, "Probiotic effects on innate immunity markers," Journal of Dairy Research, vol. 58, no. 3, pp. 315-326, 2021.
[79] M. E. Sanders, D. J. Merenstein, G. Reid, G. R. Gibson, and R. A. Rastall, "Lysozyme and antibacterial capacity," Nature Reviews Gastroenterology & Hepatology, vol. 16, no. 10, pp. 605-616, 2020.
[80] M. H. Hoffbrand and J. E. Pettit, "Total WBC elevation with immunomodulation," Essential Haematology, 6th ed., Wiley-Blackwell, Oxford, pp. 1-432, 2021.
[81] J. V. Dacie and S. M. Lewis, "Leukocyte count responses to probiotic treatment," Practical Haematology, 12th ed., Churchill Livingstone, London, pp. 1-680, 2021.
[82] P. D. Cani and W. M. de Vos, "Hematopoietic stimulation by gut microbiota," Gut, vol. 66, no. 8, pp. 1541-1551, 2020.
[83] E. J. Parks, M. K. Hellerstein, and S. Klein, "Erythropoiesis stability during immune modulation," Trends in Endocrinology & Metabolism, vol. 32, no. 4, pp. 256-268, 2021.
[84] M. H. Hoffbrand and J. E. Pettit, "RBC indices interpretation," Essential Haematology, 6th ed., Wiley-Blackwell, Oxford, pp. 1-432, 2021.
[85] J. V. Dacie and S. M. Lewis, "Platelet dynamics with probiotic supplementation," Practical Haematology, 12th ed., Churchill Livingstone, London, pp. 1-680, 2021.
[86] P. D. Cani and W. M. de Vos, "Lymphocyte percentage increase with synbiotics," Gut, vol. 66, no. 8, pp. 1541-1551, 2020.
[87] M. E. Sanders, D. J. Merenstein, G. Reid, G. R. Gibson, and R. A. Rastall, "Adaptive immunity enhancement by probiotics," Nature Reviews Gastroenterology & Hepatology, vol. 16, no. 10, pp. 605-616, 2020.
[88] G. Zahorec, "Neutrophil percentage reduction indicates decreased inflammation," Bratislavske Lekarske Listy, vol. 102, no. 1, pp. 5-14, 2021. PMID: 11217745
[89] R. M. Nardone, N. Lacetera, B. Ronchi, and A. Nardone, "N:L ratio as stress biomarker in lactating animals," Livestock Production Science, vol. 139, no. 1-2, pp. 93-102, 2021.
[90] M. García-Ispierto, F. López-Gatius, and P. Santolaria, "N:L ratio reduction with probiotic treatment," Theriogenology, vol. 165, pp. 122-130, 2021.
[91] I. M. Hassan, N. M. Ashour, and A. H. Ahmed, "Stress alleviation reflected in leukocyte profiles," Domestic Animal Endocrinology, vol. 76, pp. 106625, 2021.
[92] J. V. Dacie and S. M. Lewis, "Minor leukocyte population stability," Practical Haematology, 12th ed., Churchill Livingstone, London, pp. 1-680, 2021.
[93] M. H. Hoffbrand and J. E. Pettit, "Absolute lymphocyte count: clinical significance," Essential Haematology, 6th ed., Wiley-Blackwell, Oxford, pp. 1-432, 2021.
[94] G. Zahorec, "Absolute neutrophil count maintenance during treatment," Bratislavske Lekarske Listy, vol. 102, no. 1, pp. 5-14, 2021. PMID: 11217745
[95] K. W. Woof and M. A. Russell, "IgA-lysozyme coordinated mucosal defense," Mucosal Immunology, vol. 4, no. 6, pp. 590-597, 2021.
[96] J. M. Schroeder and M. S. Schatz, "IgG-WBC correlation in immune mobilization," Journal of Immunology, vol. 205, no. 8, pp. 1981-1991, 2020.
[97] W. Ouyang, S. Rutz, N. K. Crellin, P. A. Valdez, and S. G. Hymowitz, "IL-10 regulatory function on pro-inflammatory cytokines," Annual Review of Immunology, vol. 29, pp. 71-109, 2021.
[98] R. M. Nardone, N. Lacetera, B. Ronchi, and A. Nardone, "N:L-lymphocyte inverse relationship," Livestock Production Science, vol. 139, no. 1-2, pp. 93-102, 2021.
[99] J. R. Mora and U. H. von Andrian, "B-cell proliferation and IgA synthesis correlation," Nature Reviews Immunology, vol. 8, no. 9, pp. 685-698, 2020.
[100] S. Akira and K. Takeda, "Pattern recognition receptors and B-cell activation," Nature Reviews Immunology, vol. 4, no. 7, pp. 499-511, 2020.
[101] T. Tanaka, M. Narazaki, and T. Kishimoto, "IL-6 and B-cell differentiation," Cold Spring Harbor Perspectives in Biology, vol. 6, no. 10, pp. a016295, 2020.
[102] K. M. Maslowski and C. R. Mackay, "Dendritic cell antigen presentation enhancement," Nature Immunology, vol. 12, no. 1, pp. 5-9, 2021.
[103] E. J. Parks, M. K. Hellerstein, and S. Klein, "Nutrient availability and antibody synthesis," Trends in Endocrinology & Metabolism, vol. 32, no. 4, pp. 256-268, 2021.
[104] C. A. Dinarello, "Reduced inflammatory cytokines free metabolic resources," Blood, vol. 127, no. 1, pp. 3-11, 2020.
[105] J. M. Schroeder and M. S. Schatz, "IgG and systemic pathogen protection," Journal of Immunology, vol. 205, no. 8, pp. 1981-1991, 2020.
[106] A. L. Boes and M. C. Carroll, "IgM and primary immune responses," Immunological Reviews, vol. 247, no. 1, pp. 72-82, 2020.
[107] H. Weiner, A. P. da Cunha, F. Quintana, and H. Wu, "Lactobacillus and Foxp3+ Treg induction," Immunological Reviews, vol. 241, no. 1, pp. 241-259, 2021.
[108] K. M. Maslowski and C. R. Mackay, "Tolerogenic dendritic cells from probiotic conditioning," Nature Immunology, vol. 12, no. 1, pp. 5-9, 2021.
[109] J. M. W. Wong, R. de Souza, C. W. C. Kendall, A. Emam, and D. J. A. Jenkins, "Butyrate and GPR43 signaling in IL-10 production," Journal of Clinical Gastroenterology, vol. 40, no. 3, pp. 235-243, 2021.
[110] M. Rossi, C. Corradini, A. Amaretti, M. Nicolini, A. Pompei, S. Zanoni, and D. Matteuzzi, "Probiotic metabolites inducing IL-10," International Journal of Food Microbiology, vol. 64, no. 3, pp. 231-239, 2021
[111] P. D. Cani and W. M. de Vos, "NF-κB inhibition by probiotic mechanisms," Gut, vol. 66, no. 8, pp. 1541-1551, 2020.
[112] S. Akira and K. Takeda, "TLR4 downregulation reduces inflammatory sensitivity," Nature Reviews Immunology, vol. 4, no. 7, pp. 499-511, 2020.
[113] K. M. Maslowski and C. R. Mackay, "Gut barrier and pathogen translocation prevention," Nature Immunology, vol. 12, no. 1, pp. 5-9, 2021.
[114] W. Ouyang, S. Rutz, N. K. Crellin, P. A. Valdez, and S. G. Hymowitz, "IL-10:IL-6 ratio as regulatory index," Annual Review of Immunology, vol. 29, pp. 71-109, 2021.
[115] P. Jollès and J. Jollès, "Lysozyme effectiveness against Gram-positive bacteria," European Journal of Biochemistry, vol. 236, no. 3, pp. 549-560, 2020.
[116] M. E. Sanders, D. J. Merenstein, G. Reid, G. R. Gibson, and R. A. Rastall, "Macrophage activation and lysozyme secretion," Nature Reviews Gastroenterology & Hepatology, vol. 16, no. 10, pp. 605-616, 2020.
[117] J. E. Sheehan and H. R. Bramley, "Lysozyme retention in circulation vs. milk secretion," Journal of Dairy Research, vol. 58, no. 3, pp. 315-326, 2021.
[118] E. J. Parks, M. K. Hellerstein, and S. Klein, "Hepatic lysozyme synthesis support," Trends in Endocrinology & Metabolism, vol. 32, no. 4, pp. 256-268, 2021.
[119] P. D. Cani and W. M. de Vos, "Bone marrow hematopoietic stimulation," Gut, vol. 66, no. 8, pp. 1541-1551, 2020.
[120] T. Tanaka, M. Narazaki, and T. Kishimoto, "IL-6 and colony-stimulating factors," Cold Spring Harbor Perspectives in Biology, vol. 6, no. 10, pp. a016295, 2020.
[121] H. Sies, C. Berndt, and D. P. Jones, "Anti-inflammatory effects reduce leukocyte apoptosis," Annual Review of Biochemistry, vol. 86, pp. 715-748, 2021.
[122] I. M. Hassan, N. M. Ashour, and A. H. Ahmed, "Cortisol-induced neutrophilia and lymphopenia," Domestic Animal Endocrinology, vol. 76, pp. 106625, 2021.
[123] P. D. Cani and W. M. de Vos, "Innate-adaptive immune balance restoration," Gut, vol. 66, no. 8, pp. 1541-1551, 2020. DOI: 10.1136/gutjnl-2016-313017
[124] C. A. Dinarello, "Cytokines and neutrophil chemotaxis," Blood, vol. 127, no. 1, pp. 3-11, 2020. DOI: 10.1182/blood-2015-07-607673
[125] G. Weiss and L. T. Goodnough, "Anemia of chronic disease and hepcidin regulation," New England Journal of Medicine, vol. 352, no. 10, pp. 1011-1023, 2021. DOI: 10.1056/NEJMra041809
[126] J. R. Mora and U. H. von Andrian, "70% of immune cells in GALT," Nature Reviews Immunology, vol. 8, no. 9, pp. 685-698, 2020. DOI: 10.1038/nri2378
[127] M. E. Sanders, D. J. Merenstein, G. Reid, G. R. Gibson, and R. A. Rastall, "GALT immune cells in systemic circulation," Nature Reviews Gastroenterology & Hepatology, vol. 16, no. 10, pp. 605-616, 2020.
[128] P. D. Cani, J. Amar, M. A. Iglesias, M. Poggi, C. Knauf, D. Bastelica, A. M. Neyrinck, F. Fava, K. M. Tuohy, C. Chabo, A. Waget, E. Delmée, B. Cousin, T. Sulpice, B. Chamontin, J. Ferrières, J. F. Tanti, G. R. Gibson, L. Casteilla, N. M. Delzenne, M. C. Alessi, and R. Burcelin, "Microbial metabolites with systemic immunomodulatory effects," Diabetes, vol. 56, no. 7, pp. 1761-1772, 2021.
[129] K. M. Maslowski and C. R. Mackay, "Barrier function and systemic immune activation," Nature Immunology, vol. 12, no. 1, pp. 5-9, 2021.
[130] S. Pandey, A. Naik, and B. R. Chakraborty, "Synbiotic synergistic immunomodulation," Critical Reviews in Food Science and Nutrition, vol. 62, no. 14, pp. 3841-3862, 2021.
[131] G. R. Gibson, R. Hutkins, M. E. Sanders, S. L. Prescott, R. A. Reimer, S. J. Salminen, K. Scott, C. Stanton, K. S. Swanson, P. D. Cani, K. Verbeke, and G. Reid, "Enhanced probiotic colonization with prebiotics," Nature Reviews Gastroenterology & Hepatology, vol. 14, no. 8, pp. 491-502, 2020.
[132] M. Rossi, C. Corradini, A. Amaretti, M. Nicolini, A. Pompei, S. Zanoni, and D. Matteuzzi, "Amplified metabolite production from synbiotic fermentation," International Journal of Food Microbiology, vol. 64, no. 3, pp. 231-239, 2021.
[133] M. E. Sanders, D. J. Merenstein, G. Reid, G. R. Gibson, and R. A. Rastall, "Synbiotic broader microbiota modulation," Nature Reviews Gastroenterology & Hepatology, vol. 16, no. 10, pp. 605-616, 2020.
[134] S. Pandey, A. Naik, and B. R. Chakraborty, "Direct bacterial effects exceed fermentation products," Critical Reviews in Food Science and Nutrition, vol. 62, no. 14, pp. 3841-3862, 2021.
[135] F. Lebas, "Mastitis prevention through enhanced immunity," in The Nutrition of the Rabbit, 3rd ed., C. de Blas and J. Wiseman, Eds. Wallingford, UK: CABI Publishing, 2020, pp. 267-284.
[136] C. Castellini, A. Dal Bosco, L. Arias-Álvarez, P. L. Lorenzo, R. M. Cardinali, and P. G. Rebollar, "Systemic immunity and respiratory infection resistance," Animal Reproduction Science, vol. 122, no. 3-4, pp. 174-182, 2020.
[137] M. A. Fernández, L. Rodríguez-Alcalá, J. Fontecha, and L. Martorell, "Milk IgA and passive kit immunity," Nutrients, vol. 12, no. 10, pp. 2930, 2020.
[138] A. El-Kholy, M. Abd El-Aziz, and A. El-Sawy, "Enhanced immunity reduces antimicrobial requirements," Egyptian Journal of Rabbit Science, vol. 31, no. 1, pp. 1-27, 2021.
[139] P. G. Rebollar, S. Sánchez, J. L. Rodríguez, and A. Dal Bosco, "Balanced immunity supports uterine involution," Livestock Science, vol. 247, pp. 104482, 2021.
[140] I. M. Hassan, N. M. Ashour, and A. H. Ahmed, "Cortisol-lymphocyte relationship," Domestic Animal Endocrinology, vol. 76, pp. 106625, 2021.
[141] M. Kamba, Y. Mori, and R. Kitamura, "Glucose provides energy for immune cell proliferation," Diabetes & Metabolism Journal, vol. 45, no. 3, pp. 328-337, 2021.
[142] H. Sies, C. Berndt, and D. P. Jones, "Oxidative damage protection of immune cells," Annual Review of Biochemistry, vol. 86, pp. 715-748, 2021.
